scispace - formally typeset
K

Kevin A. Green

Researcher at University of Dundee

Publications -  17
Citations -  4365

Kevin A. Green is an academic researcher from University of Dundee. The author has contributed to research in topics: AMPK & Protein kinase A. The author has an hindex of 15, co-authored 17 publications receiving 4089 citations.

Papers
More filters
Journal ArticleDOI

CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations

TL;DR: T tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine beta-synthase bind AMP, ATP, or S-adenosyl methionine, while mutations that cause hereditary diseases impair this binding.
Journal ArticleDOI

Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation

TL;DR: The authors' approaches distinguish at least six different mechanisms for AMPK activation and confirm that the widely used antidiabetic drug metformin activates AMPK by inhibiting mitochondrial respiration.
Journal ArticleDOI

The ancient drug salicylate directly activates AMP-activated protein kinase

TL;DR: The results suggest that AMPK activation could explain some beneficial effects of salsalate and aspirin in humans, and a possible molecular mechanism of action for a metabolite of aspirin is described.
Journal ArticleDOI

Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction

TL;DR: These studies establish the importance of LKB1 in regulating AMPK activity and cellular energy levels in response to contraction and phenformin and reduce phosphorylation and activation of AMPKα2.
Journal ArticleDOI

Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.

TL;DR: Aspirin is an inhibitor of mTOR and an activator of AMPK, targeting regulators of intracellular energy homeostasis and metabolism, which could contribute to its protective effects against development of CRC.